Drug Trial Radar · NCT03597516
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Last checked: Nov 19, 2026Latest source record: Jul 8, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
557
Actual
Start
Jun 26, 2018
Primary completion
Jul 2, 2019
Study completion Jul 2, 2019
Sponsor
- Lead sponsor
- Ritter Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 24, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study conducted in the United States (US) to assess the efficacy of RP-G28 compared to placebo on symptom reduction related to lactose intolerance.
Conditions
- Lactose Intolerance
Interventions
RP-G28Drug
powder for reconstitution for oral administration
PlacebosDrug
powder for reconstitution for oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline of the Lactose Intolerance (LI) symptom composite score compared to placeboTime frame: Day 61
Locations
35 sites in 1 country. Site status is shown where the registry gives one.
Research Facility
Birmingham, Alabama
Research Site
Chula Vista, California
Research Site
Huntington Park, California
Research Site
Lincoln, California
Research Site
Los Angeles, California
Research Site
Panorama City, California
Research Site
San Diego, California
Research Site
San Diego, California
Research Site
Walnut Creek, California
Research Site
Colorado Springs, Colorado
Research Site
Gainesville, Florida
Research Facility
Miami, Florida
Research Site
Orlando, Florida
Reseaarch Site
Pompano Beach, Florida
Research Site
Honolulu, Hawaii
Research Site
Marrero, Louisiana
Research Site
Oxon Hill, Maryland
Research Site
Wyoming, Michigan
Research Site
Omaha, Nebraska
Research Site
Berlin, New Jersey
Research Site
Albuquerque, New Mexico
Research Site
Brooklyn, New York
Research Site
Great Neck, New York
Research Site
Hartsdale, New York
Research Site
Raleigh, North Carolina
Research Site
Cincinnati, Ohio
Research Site
Dayton, Ohio
Research Site
Charleston, South Carolina
Research Site
Knoxville, Tennessee
Research Site
Houston, Texas
Research Site
Lampasas, Texas
Research Site
San Antonio, Texas
Research Site
Waxahachie, Texas
Research Site
Fairfax, Virginia
Research Site
Bellevue, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.